Entry Detail



General Information

Database ID:exR0351976
RNA Name:hsa-miR-1224-5p
RNA Type:miRNA
Chromosome:chr3
Starnd:+
Coordinate:
Start Site(bp):184241405End Site(bp):184241423
External Links:hsa-miR-1224-5p



Disease Information

Disease Name:Polycystic Ovary Syndrome
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D011085
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Ovary Syndrome, Polycystic//Syndrome, Polycystic Ovary//Stein-Leventhal Syndrome//Stein Leventhal Syndrome//Syndrome, Stein-Leventhal//Sclerocystic Ovarian Degeneration//Ovarian Degeneration, Sclerocystic//Sclerocystic Ovary Syndrome//Polycystic Ovarian Syndrome//Ovarian Syndrome, Polycystic//Polycystic Ovary Syndrome 1//Sclerocystic Ovaries//Ovary, Sclerocystic//Sclerocystic Ovary



Expression Detail

GEO ID:GSE86241
Description:The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary Syndrome
Experimental Design:Disease vs Control
Case Disease Type:Polycystic Ovary Syndrome
Case Disease SubType:NA
Case Sample:Polycystic Ovary Syndrome
Control Sample:Control
Number of Case:8
Number of Control:9
Number of Samples:17





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ARF3
chr12
48935723
48957487
-
DHCR7
chr11
71428193
71452868
-
ZNF621
chr3
40524878
40574685
+
SEC14L1
chr17
77088749
77217101
+
EMC10
chr19
50476400
50490870
+
RACGAP1
chr12
49976923
50033136
-
THBD
chr20
23045633
23049672
-
ENSA
chr1
150600851
150629612
-
SLC9A3R1
chr17
74748628
74769353
+
STK4
chr20
44966479
45080021
+
LDOC1
chrX
141111605
141177129
-
UBL5
chr19
9827892
9830115
+
HOXB8
chr17
48611377
48615292
-
ANKRD52
chr12
56237807
56258384
-
TRAM2
chr6
52497408
52577060
-
RNF157
chr17
76142465
76240493
-
STC1
chr8
23841929
23854806
-
LMBR1
chr7
156668946
156893216
-
CALU
chr7
128739292
128773400
+
ATP6V1A
chr3
113747033
113812056
+
KIAA1522
chr1
32741830
32774970
+
IKBKB
chr8
42271302
42332653
+
XPO7
chr8
21919662
22006585
+
MIER3
chr5
56919602
56971675
-
DYRK1B
chr19
39825350
39834201
-
TBC1D20
chr20
435480
462543
-
MAPKAPK2
chr1
206684944
206734283
+
OPA3
chr19
45527427
45602212
-
AK2
chr1
33007940
33080996
-
FYCO1
chr3
45917899
45995824
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009133.5
chr16
29808679
29812227
+
AP000766.1
chr11
107312132
107316271
-
NEAT1
chr11
65422774
65445540
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE86241
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21575
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1951
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted from 200 ul of serum samples using the Exosomal miRNA Purification kit (Genolution, Seoul, Korea).
RNA library preparation protocol:Desalted Labeled RNA were prepared from 100ng total RNA Agilent's miRNA Complete Labeling and Hyb Kit.



Reference

PMID:27677182
Title:The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary Syndrome
Author:Song DK, Sung YA, Lee H
Journal:PLoS One. 2016 Sep 27;11(9):e0163756.
Description:The present study was performed to examine the role of the serum miRNA as a biomarker for the diagnosis of PCOS and its relationship with metabolic and reproductive traits.